the proposed mechanism involves two metal ions near the cleavable phosphate: one to stabilize the negative charge on the leaving group and one to coordinate the nucleophilic water
the apoenzyme does not contain Mg2+ in the active site, instead Mg2+ is found in helices H8 and H9 in one chain, coordinated to Leu165 N, Gln164 N and Arg161 O and possibly stabilizing this loop. The fructose 6-phosphate-bound structures contain one magnesium ion in a position that is proposed to bind fructose 1,6-bisphosphate, coordinate the 1-phosphate and stabilize the transition state
the apoenzyme does not contain Mg2+ in the active site, instead Mg2+ is found in helices H8 and H9 in one chain, coordinated to Leu165 N, Gln164 N and Arg161 O and possibly stabilizing this loop. The fructose 6-phosphate-bound structures contain one magnesium ion in a position that is proposed to bind fructose 1,6-bisphosphate, coordinate the 1-phosphate and stabilize the transition state
the apoenzyme does not contain Mg2+ in the active site, instead Mg2+ is found in helices H8 and H9 in one chain, coordinated to Leu165 N, Gln164 N and Arg161 O and possibly stabilizing this loop. The fructose 6-phosphate-bound structures contain one magnesium ion in a position that is proposed to bind fructose 1,6-bisphosphate, coordinate the 1-phosphate and stabilize the transition state
the enzyme activity is dependent on bivalent metal ions, but Co2+, Ni2+, Cu2+, Zn2+, Fe2+ and Ca2+ show no significant activation of FBPase at any specific concentration
enzyme mutant T84S can be used to trap reaction intermediates, through crystallographic methods, facilitating the design of potent inhibitors via structure-based drug design
homology modeling using the Escherichia coli enzyme structure suggests that the replacement of the critical nucleophile OH- in the Thr84 residue of the wild-type MtFBPase by Ser84 results in subtle alterations of the position and orientation that reduce the catalytic efficiency
x * 36584, recombinant mutant T84A, mass spectrometry and sequence calculation, x * 36599, recombinant mutant T84S, mass spectrometry and sequence calculation
the constellation of amino-acid residues in the active site of FBPaseII from Mycobacterium tuberculosis (MtFBPaseII) is conserved and is analogous to that described previously for the Escherichia coli enzyme, structure analysis and comparisons, overview
the constellation of amino-acid residues in the active site of FBPaseII from Mycobacterium tuberculosis (MtFBPaseII) is conserved and is analogous to that described previously for the Escherichia coli enzyme, structure analysis and comparisons, overview
the constellation of amino-acid residues in the active site of FBPaseII from Mycobacterium tuberculosis (MtFBPaseII) is conserved and is analogous to that described previously for the Escherichia coli enzyme, structure analysis and comparisons, overview
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CRYSTALLIZATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
purified recombinant wild-type apoform and two active site mutants T84A and T84S in complex with D-fructose 1,6-bisphosphate or D-fructose 6-phosphate (F6P), hanging drop vapor diffusion method, mixing of protein and precipitant solution in a 1:1 ratio, the reservoir solution contains 1.0 M ammonium citrate tribasic, pH 7.0, and 1% PEG 3350, for the apoenzyme, and 2.4 M sodium malonate, pH 6.0, with 1 mM ligand, for the complexed mutant enzyme crystals, X-ray diffraction structure determination and analysis at 2.6 A, 2.3 A, and 2.2 A resolution, respectively, crystal structures of apo MtFBPaseII, the T84A MtFBPase-F6P complex and the T84S MtFBPase-F6P complex are solved by molecular replacement
hanging-drop vapor-diffusion method at 25°C, crystal structures of native enzyme (FBPaseII) at 2.6 A resolution and two active-site protein variants. The variants are complexed with the reaction product fructose 6-phosphate. Presence of a 222 tetramer
purified recombinant His-tagged enzyme, hanging-drop vapor-diffusion method, 0.001 ml of protein solution containing 10 mg/ml protein, is mixed with 0.001 ml of reservoir solution containing 1.8 M ammonium citrate tribasic, pH 7.0, and equilibratzion against 0.3 ml reservoir solution, 72 h to 2 weeks, X-ray diffraction structure determination and analysis at 2.7 A resolution, molecular replacement
site-directed mutagenesis, the codon ACC for Thr84 is replaced by GCA for alanine, the active site mutant shows fully abolished enzyme activity while retaining substrate binding affinity
site-directed mutagenesis, active-site mutant, the mutant shows reduced activity compared to wild-type. One Mg2+ ion is found in T84S MtFBPaseII, coordinated to a glycerol molecule and to Asp79, Asp82, and Glu208 near the cleaved 1-phosphate group of the substrate
site-directed mutagenesis, the codon ACC for Thr84 is replaced by AGC for serine, the active site mutant retains some activity having a 10times reduction in Vmax and exhibit similar sensitivity to lithium when compared to the wild-type enzyme
mutantion retains some activity having a 10 times reduction in Vmax and exhibits similar sensitivity to lithium when compared to the wild-type enzyme. Homology modeling using the Escherichia coli enzyme structure suggests that the replacement of the critical nucleophile OH- in the Thr84 residue of the wild-type enzyme by Ser84 results in subtle alterations of the position and orientation that reduces the catalytic efficiency. This mutant can be used to trap reaction intermediates, through crystallographic methods, facilitating the design of potent inhibitors via structure-based drug design
recombinant His-tagged wild-type and mutant enzymes from Escherichia coli strain BL21(DE3) by nickel affinity chromatography, ultrafiltration, and desalting gel filtration
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
gene glpX, sequence comparisons of class II FBPases, recombinant expression of His-tagged wild-type and mutant enzymes in Escherichia coli strain BL21(DE3)
Gutka, H.J.; Rukseree, K.; Wheeler, P.R.; Franzblau, S.G.; Movahedzadeh, F.
glpX gene of Mycobacterium tuberculosis: heterologous expression, purification, and enzymatic characterization of the encoded fructose 1,6-bisphosphatase II
Wolf, N.; Gutka, H.; Movahedzadeh, F.; Abad-Zapatero, C.
Structures of the mycobacterium tuberculosis glpx protein (Class II fructose-1,6-bisphosphatase) Implications for the active oligomeric state, catalytic mechanism and citrate inhibition
Bondoc, J.; Wolf, N.; Ndichuck, M.; Abad-Zapatero, C.; Movahedzadeh, F.
Mutagenesis of threonine to serine in the active site of Mycobacterium tuberculosis fructose-1,6-bisphosphatase (Class II) retains partial enzyme activity